Klotho acts as a tumor suppressor in cancers

Pathology and Oncology Research

Volumn 19, Issue 4, 2013, Pages 611-617

  Xie, Biao ^a,b   Chen, Jinhui ^a   Liu, Bin ^a   Zhan, Junkun ^b  

^a 8th Changsha Hospital   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Autophagy; Insulin IGF1 axis; Klotho; ROS; Wnt signaling

Indexed keywords

INSULIN; KLOTHO PROTEIN; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; WNT PROTEIN;

AUTOPHAGY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RESISTANCE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; DEACETYLATION; DNA METHYLATION; GENE FUNCTION; GENE SILENCING; HISTONE DEACETYLATION; HUMAN; KLOTHO GENE; NONHUMAN; PROMOTER REGION; REVIEW; TUMOR SUPPRESSOR GENE; WNT SIGNALING PATHWAY;

ANIMALS; AUTOPHAGY; GENES, TUMOR SUPPRESSOR; GLUCURONIDASE; HUMANS; MICE; NEOPLASMS;

EID: 84885182550     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9663-8     Document Type: Review

References (79)

1. Kuro-o M, Matsumura Y, Aizawa H et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51
2. Kurosu H, Yamamoto M, Clark JD et al (2005) Suppression of aging in mice by the hormone Klotho. Science 309:1829-1833
3. Torres PU, Prié D, Beck L, De Brauwere D, Leroy C, Friedlander G (2009) Klotho gene, phosphocalcic metabolism, and survival in dialysis. J Ren Nutr 19:50-56
4. Kuro-o M (2012) Klotho in health and disease. Curr Opin Nephrol Hypertens 21:362-368
5. Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H (2008) Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. Cancer Invest 26:185-192
6. Wolf I, Levanon-Cohen S, Bose S et al (2008) Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27:7094-7105
7. Wolf I, Laitman Y, Rubinek T et al (2010) Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. Oncogene 29:26-33
8. Laitman Y, Kuchenbaecker KB, Rantala J et al (2012) The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 132:1119-1126
9. Chen B, Wang X, Zhao W, Wu J (2010) Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549. J Exp Clin Cancer Res 29:99-106
10. Lee J, Jeong DJ, Kim J et al (2010) The antiaging gene KLOTHO is a novel target for epigenetic silencing inhuman cervical carcinoma. Mol Cancer 9:109-118
11. Wang LJ, Wang X, Wang XJ et al (2011) Klotho is silenced through promoter hypermethylation in gastric cancer. Am J Cancer Res 1:111-119
12. Abramovitz L, Rubinek T, Ligumsky H et al (2011) KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer. Clin Cancer Res 17:4254-4266
13. Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E (2001) Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res 61:6747-6754
14. Pan J, Zhong J, Gan LH et al (2011) Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer. Tumour Biol 32:729-735
15. Rubinek T, Shulman M, Israeli S, et al. (2011) Epigenetic silencing of the tumor suppressor klotho in human breast cancer. Breast Cancer Res Treat [Epub ahead of print]
16. Wang X, Chen B, Xu W, Liu S, Zhao W, Wu J (2011) Combined effects of klotho and soluble CD40 ligand on A549 lung cancer cells. Oncol Rep 25:1465-1472
17. Doi S, Zou Y, Togao O et al (2011) Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. Biol Chem 286:8655-8665
18. Shu G, Xie B, Ren F, et al. (2012) Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells. Cell Oncol (Dordr) [Epub ahead of print]
19. Xie B, Zhou J, Yuan L, et al. (2012) Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma. Hum Pathol
20. Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505-518
21. Evans DS, Kapahi P, Hsueh WC, Kockel L (2011) TOR signaling never gets old: aging, longevity and TORC1 activity. Ageing Res Rev 10:225-237
22. Carboni JM, Lee AV, Hadsell DL et al (2005) Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 5:3781-3787
23. Lopez T, Hanahan D (2002) Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 1:339-353
24. Yakar S, Leroith D, Brodt P (2005) The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev 16:407-420
25. Yakar S, Leroith D, Brodt P (2005) The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev 6:407-420
26. Usuda J, Ichinose S, Ishizumi T et al (2011) Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung. Lung Cancer 72:355-359
27. Usuda J, Ichinose S, Ishizumi T et al (2011) Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery. Lung Cancer 74:332-337
28. Xie B, Zhou J, Shu G et al (2013) Restoration of klotho gene expression induces apoptosis and autophagy in gastric cancer cells: tumor suppressive role of klotho in gastric cancer. Cancer Cell Int 13:18
29. Chihara Y, Rakugi H, Ishikawa K et al (2006) Klotho protein promotes adipocyte differentiation. Endocrinology 147:3835-3842
30. Lorenzi O, Veyrat-Durebex C, Wollheim CB et al (2010) Evidence against a direct role of klotho in insulin resistance. Pflugers Arch 459:465-473
31. Duce JA, Podvin S, Hollander W et al (2008) Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey. Glia 56:106-117
32. Choi BH, Kim CG, Lim Y, Lee YH, Shin SY (2010) Transcriptional activation of the human Klotho gene by epidermal growth factor in HEK293 cells; role of Egr-1. Gene 450:121-127
33. Shen J, Stass SA, Jiang F (2013) MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 329:125-136
34. Liang R, Bates DJ, Wang E (2009) Epigenetic Control of MicroRNA Expression and Aging. Curr Genomics 10:184-193
35. Maes OC, An J, Sarojini H, Wang E (2008) Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev 129:534-541
36. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810
37. Klaus A, Birchmeier W (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8:387-398
38. Suzuki H, Watkins DN, Jair KW et al (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36:417-422
39. Urakami S, Shiina H, Enokida H et al (2006) Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 12:2109-2116
40. Nojima M, Suzuki H, Toyota M et al (2007) Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 26:4699-4713
41. Suzuki H, Toyota M, Carraway H et al (2008) Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 98:1147-1156
42. Camilli TC, Xu M, O'Connell MP et al (2011) Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Pigment Cell Melanoma Res 24:175-186
43. Liu H, Fergusson MM, Castilho RM et al (2007) Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317:803-806
44. Kirstetter P, Anderson K, Porse BT, Jacobsen SE, Nerlov C (2006) Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol 7:1048-1056
45. Nusse R (2008) Wnt signaling and stem cell control. Cell Res 18:523-527
46. Castilho RM, Squarize CH, Chodosh LA, Williams BO, Gutkind JS (2009) mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 4:279-289
47. Scheller M, Huelsken J, Rosenbauer F et al (2006) Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat Immunol 7:1037-1047
48. Wang Y, Sun Z (2009) Current understanding of klotho. Ageing Res Rev 8:43-51
49. Stone JR, Yang S (2006) Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8:243-270
50. Mahadev K, Wu X, Zilbering A et al (2001) Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276:48662-48669
51. Colavitti R, Pani G, Bedogni B et al (2002) Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 277:3101-3108
52. Wang Y, Sun Z (2009) Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54:810-817
53. Mitobe M, Yoshida T, Sugiura H et al (2005) Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol 101:67-74
54. Kuro-o M (2008) Klotho as a regulator of oxidative stress and senescence. Biol Chem 389:233-241
55. Panayiotidis M (2008) Reactive oxygen species (ROS) in multistage carcinogenesis. Cancer Lett 266:3-5
56. Lee SB, Cho ES, Yang HS, Kim H, Um HD (2005) Serum withdrawal kills U937 cells by inducing a positive mutual interaction between reactive oxygen species and phosphoinositide 3-kinase. Cell Signal 17:197-204
57. Cao Q, Mak KM, Lieber CS (2006) DLPC and SAMe prevent alpha1(I) collagen mRNA up-regulation in human hepatic stellate cells, whether caused by leptin or menadione. Biochem Biophys Res Commun 350:50-55
58. Nicco C, Laurent A, Chereau C, Weill B, Batteux F (2005) Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother 59:169-174
59. López-Lázaro M (2007) Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 252:1-8
60. Zielonka J, Kalyanaraman B (2008) "ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis"-a critical commentary. Free Radic Biol Med 45:1217-1219
61. Scherz-Shouval R, Shvets E, Fass E et al (2007) Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26:1749-1760
62. Juhász G, Erdi B, Sass M, Neufeld TP (2007) Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev 21:3061-3066
63. Kuma A, Hatano M, Matsui M et al (2004) The role of autophagy during the early neonatal starvation period. Nature 432:1032-1036
64. Meléndez A, Tallóczy Z, Seaman M et al (2003) Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 301:1387-1391
65. Yamamoto M, Clark JD, Pastor JV et al (2005) Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 280:38029-38034
66. Saito K, Ishizaka N, Mitani H, Ohno M, Nagai R (2003) Iron chelation and a free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat. FEBS Lett 551:58-62
67. Afanas'ev I (2010) Reactive oxygen species and age-related genes p66shc, Sirtuin, FOX03 and Klotho in senescence. Oxid Med Cell Longev 3:77-85
68. Iwasaki Y, Nishiyama M, Taguchi T et al (2009) Insulin exhibits short-term anti-inflammatory but long-term proinflammatory effects in vitro. Mol Cell Endocrinol 298:25-32
69. Salminen A, Huuskonen J, Ojala J et al (2008) Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 7:83-105
70. Salminen A, Kaarniranta K (2009) Regulation of the aging process by autophagy. Trends Mol Med 15:217-224
71. Eskelinen EL, Saftig P (2004) Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 1793:664-673
72. Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23:2891-2906
73. Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E (2005) Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1:84-91
74. Bunney TD, Katan M (2010) Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer 10:342-352
75. Huang J, Manning BD (2009) A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 37:217-222
76. Degtyarev M, De Mazière A, Orr C et al (2008) Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol 183:101-116
77. Arico S, Petiot A, Bauvy C et al (2001) The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 276:35243-35246
78. Mammucari C, Milan G, Romanello V et al (2007) FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6:458-471
79. Iida RH, Kanko S, Suga T, Morito M, Yamane A (2011) Autophagic-lysosomal pathway functions in the masseter and tongue muscles in the klotho mouse, a mouse model for aging. Mol Cell Biochem 348:89-98